Related references
Note: Only part of the references are listed.T cells redirected to interleukin-13Rα2 with interleukin-13 mutein-chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1
Simone Krebs et al.
CYTOTHERAPY (2014)
Engineering T cells for cancer: our synthetic future
Robert H. Vonderheide et al.
IMMUNOLOGICAL REVIEWS (2014)
Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells
Michael C. Jensen et al.
IMMUNOLOGICAL REVIEWS (2014)
Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma
Bryan D. Choi et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2014)
Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide
Jiongbo Liao et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy
Bart Thaci et al.
NEURO-ONCOLOGY (2014)
Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection
Pappanaicken R. Kumaresan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma
Meenakshi Hegde et al.
MOLECULAR THERAPY (2013)
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
Kevin K. H. Chow et al.
MOLECULAR THERAPY (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis
Christine E. Brown et al.
PLOS ONE (2013)
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain et al.
CANCER DISCOVERY (2013)
Genetically modified T cells to target glioblastoma
Simone Krebs et al.
FRONTIERS IN ONCOLOGY (2013)
Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy
Sadhak Sengupta et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor-Modified T Cells
Seogkyoung Kong et al.
CLINICAL CANCER RESEARCH (2012)
Stem-like Tumor-Initiating Cells Isolated from IL13Rα2 Expressing Gliomas Are Targeted and Killed by IL13-Zetakine-Redirected T Cells
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2012)
Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele
Kenichiro Iwami et al.
CYTOTHERAPY (2012)
Recent developments on immunotherapy for brain cancer
Derek A. Wainwright et al.
EXPERT OPINION ON EMERGING DRUGS (2012)
Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
Richard A. Morgan et al.
HUMAN GENE THERAPY (2012)
Characterization and Immunotherapeutic Implications for a Novel Antibody Targeting Interleukin (IL)-13 Receptor α2
Irina V. Balyasnikova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
An interleukin 13 receptor alpha 2-specific peptide homes to human Glioblastoma multiforme xenografts
Hetal Pandya et al.
NEURO-ONCOLOGY (2012)
Glioblastoma Presenting with Steroid-Induced Pseudoregression of Contrast Enhancement on Magnetic Resonance Imaging
Marcus D. Mazur et al.
CASE REPORTS IN NEUROLOGICAL MEDICINE (2012)
Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
Camilo E. Fadul et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Treating cancer with genetically engineered T cells
Tristen S. Park et al.
TRENDS IN BIOTECHNOLOGY (2011)
Chimeric Antigen Receptor Therapy for B-cell Malignancies
David L. Porter et al.
JOURNAL OF CANCER (2011)
HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
Nabil Ahmed et al.
CLINICAL CANCER RESEARCH (2010)
Challenges in Clinical Design of Immunotherapy Trials for Malignant Glioma
Cleo E. Rolle et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2010)
Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics
Marianela Candolfi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
DCVax®-Brain and DC vaccines in the treatment of GBM
Christopher J. Wheeler et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Genetically engineered T cells to target EGFRvIII expressing glioblastoma
Szofia S. Bullain et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy
Guido Frosina
MOLECULAR CANCER RESEARCH (2009)
Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model
Achuthamangalam B. Madhankumar et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Noninvasive detection of therapeutic cytolytic T cells with F-18-FHBG PET in a patient with glioma
Shahriar S. Yaghoubi et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2009)
Second-Generation Anti-Carcinoembryonic Antigen Designer T Cells Resist Activation-induced Cell Death, Proliferate on Tumor Contact, Secrete Cytokines, and Exhibit Superior Antitumor Activity In vivo: A Preclinical Evaluation
Peter C. R. Emtage et al.
CLINICAL CANCER RESEARCH (2008)
Identification of a human leukocyte antigen-A24-restricted T-cell epitope derived from interleukin-13 receptor α2 chain, a glioma-associated antigen
Shinji Shimato et al.
JOURNAL OF NEUROSURGERY (2008)
Targeting IL-13Rα2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin
Mitomu Kioi et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study
Amy B. Heimberger et al.
NEURO-ONCOLOGY (2008)
Change in expression of MGMT during maturation of human monocytes into dendritic cells
Manuela Briegert et al.
DNA REPAIR (2007)
Dexamethasone inhibits proliferation and stimulates ecto-5'-nucleotidase/CD73 activity in C6 rat glioma cell line
Luci Bavaresco et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Novel recombinant adenoviral vector that targets the interleukin-13 receptor α2 chain permits effective gene transfer to malignant glioma
Ilya V. Ulasov et al.
HUMAN GENE THERAPY (2007)
Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics
Jian Gang Zhang et al.
CLINICAL CANCER RESEARCH (2007)
Human monocytes, but not dendritic cells derived from them, are defective in base excision repair and hypersensitive to methylating agents
Manuela Briegert et al.
CANCER RESEARCH (2007)
Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression
Mark Lowenberg et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13R alpha 2, gp100 and TRP-2 for immunotherapy
Stephan Saikali et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme
A. B. Madhankumar et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Recent advances in immunotherapy for human glioma
Antoine E. Carpentier et al.
CURRENT OPINION IN ONCOLOGY (2006)
Characterization of the interaction between interleukin-13 and interleukin-13 receptors
K Arima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme
Y Liang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Analysis of interleukin-13 receptor α2 expression in human pediatric brain tumors
M Kawakami et al.
CANCER (2004)
Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells
KS Kahlon et al.
CANCER RESEARCH (2004)
Protection and in vivo selection of hematopoietic stem cells using temozolomide, O-6-benzylguanine, and an alkyltransferase-expressing retroviral vector
N Sawai et al.
MOLECULAR THERAPY (2001)
Share Paper
